僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Actoxumab （Anti-C. difficile Toxin A Recombinant Antibody） is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab （HY-P9929） targeting TcdB